{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T08:09:34Z","timestamp":1775376574808,"version":"3.50.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T00:00:00Z","timestamp":1642896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T00:00:00Z","timestamp":1642896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001412","name":"council\u00a0of\u00a0scientific and industrial research, india","doi-asserted-by":"publisher","award":["OLP-2035"],"award-info":[{"award-number":["OLP-2035"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"science and engineering research board","doi-asserted-by":"publisher","award":["GPP-0329"],"award-info":[{"award-number":["GPP-0329"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s11033-021-07095-1","type":"journal-article","created":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T00:04:21Z","timestamp":1642896261000},"page":"3987-4002","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Alterations in molecular response of Mycobacterium tuberculosis against anti-tuberculosis drugs"],"prefix":"10.1007","volume":"49","author":[{"given":"Abhilash","family":"Bhattacharjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangita","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tejosmita","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0375-9242","authenticated-orcid":false,"given":"Anil Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,23]]},"reference":[{"key":"7095_CR1","doi-asserted-by":"publisher","first-page":"e3426","DOI":"10.1371\/journal.pone.0003426","volume":"3","author":"I Hershkovitz","year":"2008","unstructured":"Hershkovitz I, Donoghue HD, Minnikin DE et al (2008) Detection and molecular characterization of 9000-year-old Mycobacterium tuberculosis from a neolithic settlement in the Eastern Mediterranean. PLoS ONE 3:e3426. https:\/\/doi.org\/10.1371\/journal.pone.0003426","journal-title":"PLoS ONE"},{"key":"7095_CR2","volume-title":"Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis","author":"Organization, WH","year":"2014","unstructured":"Organization, WH et al (2014) Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. World Health Organization, Geneva"},{"key":"7095_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s2213-2600(19)30418-7","volume":"8","author":"E Harding","year":"2020","unstructured":"Harding E (2020) WHO global progress report on tuberculosis elimination. Lancet Respir Med 8:19. https:\/\/doi.org\/10.1016\/s2213-2600(19)30418-7","journal-title":"Lancet Respir Med"},{"key":"7095_CR4","volume-title":"Global Tuberculosis Report 2019","author":"Organization, WH","year":"2019","unstructured":"Organization, WH et al (2019) Global Tuberculosis Report 2019. World Health Organization, Geneva"},{"key":"7095_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.02.107","author":"J Chakaya","year":"2021","unstructured":"Chakaya J, Khan M, Ntoumi F et al (2021) Global Tuberculosis Report 2020 \u2013 Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. https:\/\/doi.org\/10.1016\/j.ijid.2021.02.107","journal-title":"Int J Infect Dis"},{"key":"7095_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1590\/s1806-37562017000000436","volume":"44","author":"DR Silva","year":"2018","unstructured":"Silva DR, Dalcolmo M, Tiberi S et al (2018) New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis. J Bras Pneumol 44:153\u2013160. https:\/\/doi.org\/10.1590\/s1806-37562017000000436","journal-title":"J Bras Pneumol"},{"key":"7095_CR7","doi-asserted-by":"publisher","first-page":"e25956","DOI":"10.7554\/eLife.25956","volume":"6","author":"M Pai","year":"2017","unstructured":"Pai M, Furin J (2017) Point of View: Tuberculosis innovations mean little if they cannot save lives. Elife 6:e25956","journal-title":"Elife"},{"key":"7095_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-20478-9","volume-title":"Practical and laboratory diagnosis of tuberculosis: from sputum smear to molecular biology","author":"G Garc\u00eda-Elorriaga","year":"2015","unstructured":"Garc\u00eda-Elorriaga G, del Rey-Pineda G (2015) Practical and laboratory diagnosis of tuberculosis: from sputum smear to molecular biology. Springer, New York"},{"key":"7095_CR9","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1183\/09031936.00184312","volume":"42","author":"V Melchionda","year":"2013","unstructured":"Melchionda V, Wyatt H, Capocci S et al (2013) Amikacin treatment for multidrug resistant tuberculosis: how much monitoring is required?: Table 1\u2013. Eur Respir J 42:1148\u20131150. https:\/\/doi.org\/10.1183\/09031936.00184312","journal-title":"Eur Respir J"},{"key":"7095_CR10","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1093\/jac\/dkz319","volume":"74","author":"M Muliaditan","year":"2019","unstructured":"Muliaditan M, Della Pasqua O (2019) How long will treatment guidelines for TB continue to overlook variability in drug exposure? J Antimicrob Chemother 74:3274\u20133280. https:\/\/doi.org\/10.1093\/jac\/dkz319","journal-title":"J Antimicrob Chemother"},{"key":"7095_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1128\/aac.46.2.267-274.2002","volume":"46","author":"SH Gillespie","year":"2002","unstructured":"Gillespie SH (2002) Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob Agents Chemother 46:267\u2013274. https:\/\/doi.org\/10.1128\/aac.46.2.267-274.2002","journal-title":"Antimicrob Agents Chemother"},{"key":"7095_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/femsre\/fux011","volume":"41","author":"SM Gygli","year":"2017","unstructured":"Gygli SM, Borrell S, Trauner A, Gagneux S (2017) Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives. FEMS Microbiol Rev 41:354\u2013373. https:\/\/doi.org\/10.1093\/femsre\/fux011","journal-title":"FEMS Microbiol Rev"},{"key":"7095_CR13","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1128\/aac.00610-10","volume":"54","author":"M Balganesh","year":"2010","unstructured":"Balganesh M, Kuruppath S, Marcel N et al (2010) Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discovery. Antimicrob Agents Chemother 54:5167\u20135172. https:\/\/doi.org\/10.1128\/aac.00610-10","journal-title":"Antimicrob Agents Chemother"},{"key":"7095_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1590\/s1517-83822014005000032","volume":"45","author":"J Wei","year":"2014","unstructured":"Wei J, Liang J, Shi Q et al (2014) Genome-wide transcription analyses in Mycobacterium tuberculosis treated with lupulone. Braz J Microbiol 45:333\u2013342. https:\/\/doi.org\/10.1590\/s1517-83822014005000032","journal-title":"Braz J Microbiol"},{"key":"7095_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1128\/aac.48.1.143-150.2004","volume":"48","author":"K Buri\u00e1nkov\u00e1","year":"2004","unstructured":"Buri\u00e1nkov\u00e1 K, Doucet-Populaire F, Dorson O et al (2004) Molecular basis of intrinsic macrolide resistance in the Mycobacterium tuberculosis complex. Antimicrob Agents Chemother 48:143\u2013150. https:\/\/doi.org\/10.1128\/aac.48.1.143-150.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"7095_CR16","doi-asserted-by":"publisher","first-page":"12200","DOI":"10.1073\/pnas.0505446102","volume":"102","author":"RP Morris","year":"2005","unstructured":"Morris RP, Nguyen L, Gatfield J et al (2005) Ancestral antibiotic resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 102:12200\u201312205. https:\/\/doi.org\/10.1073\/pnas.0505446102","journal-title":"Proc Natl Acad Sci USA"},{"key":"7095_CR17","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1128\/aac.00550-09","volume":"53","author":"S Ramon-Garcia","year":"2009","unstructured":"Ramon-Garcia S, Martin C, Thompson CJ, A\u00ednsa JA (2009) Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob Agents Chemother 53:3675\u20133682. https:\/\/doi.org\/10.1128\/aac.00550-09","journal-title":"Antimicrob Agents Chemother"},{"key":"7095_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev-pharmtox-010617-052438","volume":"58","author":"LHM te Brake","year":"2018","unstructured":"te Brake LHM, de Knegt GJ, de Steenwinkel JE et al (2018) The role of efflux pumps in tuberculosis treatment and their promise as a target in drug development: unraveling the black box. Annu Rev Pharmacol Toxicol 58:271\u2013291. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010617-052438","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"7095_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.tim.2004.11.010","volume":"13","author":"CA Fux","year":"2005","unstructured":"Fux CA, Costerton JW, Stewart PS, Stoodley P (2005) Survival strategies of infectious biofilms. Trends Microbiol 13:34\u201340. https:\/\/doi.org\/10.1016\/j.tim.2004.11.010","journal-title":"Trends Microbiol"},{"key":"7095_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bbrc.2010.08.023","volume":"400","author":"J-S Han","year":"2010","unstructured":"Han J-S, Lee JJ, Anandan T et al (2010) Characterization of a chromosomal toxin\u2013antitoxin, Rv1102c\u2013Rv1103c system in Mycobacterium tuberculosis. Biochem Biophys Res Commun 400:293\u2013298. https:\/\/doi.org\/10.1016\/j.bbrc.2010.08.023","journal-title":"Biochem Biophys Res Commun"},{"key":"7095_CR21","doi-asserted-by":"publisher","first-page":"9728","DOI":"10.1021\/bi7008695","volume":"46","author":"ET Yukl","year":"2007","unstructured":"Yukl ET, Ioanoviciu A, de Montellano PRO, Mo\u00ebnne-Loccoz P (2007) Interdomain interactions within the two-component heme-based sensor DevS from Mycobacterium tuberculosis\u2020. Biochemistry 46:9728\u20139736. https:\/\/doi.org\/10.1021\/bi7008695","journal-title":"Biochemistry"},{"key":"7095_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1074\/jbc.m111.302588","volume":"287","author":"J Burian","year":"2011","unstructured":"Burian J, Ram\u00f3n-Garc\u00eda S, Sweet G et al (2011) The mycobacterial transcriptional regulator whiB7Gene links Redox homeostasis and intrinsic antibiotic resistance. J Biol Chem 287:299\u2013310. https:\/\/doi.org\/10.1074\/jbc.m111.302588","journal-title":"J Biol Chem"},{"key":"7095_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nrmicro.2016.131","volume":"14","author":"MI Gr\u00f6schel","year":"2016","unstructured":"Gr\u00f6schel MI, Sayes F, Simeone R et al (2016) ESX secretion systems: mycobacterial evolution to counter host immunity. Nat Rev Microbiol 14:677\u2013691","journal-title":"Nat Rev Microbiol"},{"key":"7095_CR24","volume-title":"The resistance phenomenon in microbes and infectious disease vectors: implications for human health and strategies for containment: workshop summary","author":"T Burroughs","year":"2003","unstructured":"Burroughs T, Najafi M, Lemon SM et al (2003) The resistance phenomenon in microbes and infectious disease vectors: implications for human health and strategies for containment: workshop summary. National Academies Press, Washington, DC"},{"issue":"6318","key":"7095_CR25","doi-asserted-by":"publisher","first-page":"aaf4268","DOI":"10.1126\/science.aaf4268","volume":"354","author":"A Harms","year":"2016","unstructured":"Harms A, Maisonneuve E, Gerdes K (2016) Mechanisms of bacterial persistence during stress and antibiotic exposure. Science 354(6318):aaf4268","journal-title":"Science"},{"key":"7095_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev.micro.112408.134306","volume":"64","author":"K Lewis","year":"2010","unstructured":"Lewis K (2010) Persister cells. Annu Rev Microbiol 64:357\u2013372. https:\/\/doi.org\/10.1146\/annurev.micro.112408.134306","journal-title":"Annu Rev Microbiol"},{"key":"7095_CR27","doi-asserted-by":"publisher","first-page":"e1001065","DOI":"10.1371\/journal.pbio.1001065","volume":"9","author":"S-H Baek","year":"2011","unstructured":"Baek S-H, Li AH, Sassetti CM (2011) Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol 9:e1001065. https:\/\/doi.org\/10.1371\/journal.pbio.1001065","journal-title":"PLoS Biol"},{"key":"7095_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41579-018-0013-4","volume":"16","author":"S Ehrt","year":"2018","unstructured":"Ehrt S, Schnappinger D, Rhee KY (2018) Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis. Nat Rev Microbiol 16:496\u2013507. https:\/\/doi.org\/10.1038\/s41579-018-0013-4","journal-title":"Nat Rev Microbiol"},{"key":"7095_CR29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrmicro3448","volume":"13","author":"V Hauryliuk","year":"2015","unstructured":"Hauryliuk V, Atkinson GC, Murakami KS et al (2015) Recent functional insights into the role of (p)ppGpp in bacterial physiology. Nat Rev Microbiol 13:298\u2013309. https:\/\/doi.org\/10.1038\/nrmicro3448","journal-title":"Nat Rev Microbiol"},{"key":"7095_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","volume":"14","author":"A Brauner","year":"2016","unstructured":"Brauner A, Fridman O, Gefen O, Balaban NQ (2016) Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol 14:320\u2013330. https:\/\/doi.org\/10.1038\/nrmicro.2016.34","journal-title":"Nat Rev Microbiol"},{"key":"7095_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5653424","volume":"2019","author":"Y Yang","year":"2019","unstructured":"Yang Y, Wu J (2019) Significance of the differential peptidome in multidrug-resistant tuberculosis. Biomed Res Int 2019:1\u201312. https:\/\/doi.org\/10.1155\/2019\/5653424","journal-title":"Biomed Res Int"},{"key":"7095_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/femsre\/fuz016","volume":"43","author":"A Maitra","year":"2019","unstructured":"Maitra A, Munshi T, Healy J et al (2019) Cell wall peptidoglycan in Mycobacterium tuberculosis: an Achilles\u2019 heel for the TB-causing pathogen. FEMS Microbiol Rev 43:548\u2013575. https:\/\/doi.org\/10.1093\/femsre\/fuz016","journal-title":"FEMS Microbiol Rev"},{"key":"7095_CR33","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1126\/science.1164571","volume":"322","author":"R Singh","year":"2008","unstructured":"Singh R, Manjunatha U, Boshoff HIM et al (2008) PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science 322:1392\u20131395. https:\/\/doi.org\/10.1126\/science.1164571","journal-title":"Science"},{"key":"7095_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fmicb.2019.00249","volume":"10","author":"J Briffotaux","year":"2019","unstructured":"Briffotaux J, Liu S, Gicquel B (2019) Genome-wide transcriptional responses of Mycobacterium to antibiotics. Front Microbiol 10:249. https:\/\/doi.org\/10.3389\/fmicb.2019.00249","journal-title":"Front Microbiol"},{"key":"7095_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1128\/AAC.01461-17","volume":"61","author":"L de Welzen","year":"2017","unstructured":"de Welzen L, Eldholm V, Maharaj K et al (2017) Whole-transcriptome and -genome analysis of extensively drug-resistant Mycobacterium tuberculosis clinical isolates identifies downregulation of ethA as a mechanism of ethionamide resistance. Antimicrob Agents Chemother 61:61\u20137. https:\/\/doi.org\/10.1128\/AAC.01461-17","journal-title":"Antimicrob Agents Chemother"},{"key":"7095_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bsheal.2020.02.004","volume":"2","author":"L Zhan","year":"2020","unstructured":"Zhan L, Wang J, Wang L, Qin C (2020) The correlation of drug resistance and virulence in Mycobacterium tuberculosis. Biosaf Health 2:18\u201324","journal-title":"Biosaf Health"},{"key":"7095_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-2958.1995.tb02238.x","volume":"15","author":"B Heym","year":"1995","unstructured":"Heym B, Alzari PM, Honore N, Cole ST (1995) Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol 15:235\u2013245. https:\/\/doi.org\/10.1111\/j.1365-2958.1995.tb02238.x","journal-title":"Mol Microbiol"},{"key":"7095_CR38","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1038\/s41598-018-21378-x","volume":"8","author":"P Lempens","year":"2018","unstructured":"Lempens P, Meehan CJ, Vandelannoote K et al (2018) Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations. Sci Rep 8:3246. https:\/\/doi.org\/10.1038\/s41598-018-21378-x","journal-title":"Sci Rep"},{"key":"7095_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02133-16","author":"MA DeJesus","year":"2017","unstructured":"DeJesus MA, Gerrick ER, Xu W et al (2017) Comprehensive essentiality analysis of the Mycobacterium tuberculosis genome via saturating transposon mutagenesis. mBio. https:\/\/doi.org\/10.1128\/mbio.02133-16","journal-title":"mBio"},{"key":"7095_CR40","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1128\/aac.47.9.2903-2913.2003","volume":"47","author":"JC Betts","year":"2003","unstructured":"Betts JC, McLaren A, Lennon MG et al (2003) Signature gene expression profiles discriminate between Isoniazid-, Thiolactomycin-, and Triclosan-treated Mycobacterium tuberculosis. Antimicrob Agents Chemother 47:2903\u20132913. https:\/\/doi.org\/10.1128\/aac.47.9.2903-2913.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"7095_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.tube.2003.12.005","volume":"84","author":"SJ Waddell","year":"2004","unstructured":"Waddell SJ, Stabler RA, Laing K et al (2004) The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. Tuberculosis 84:263\u2013274. https:\/\/doi.org\/10.1016\/j.tube.2003.12.005","journal-title":"Tuberculosis"},{"key":"7095_CR42","doi-asserted-by":"publisher","first-page":"e0119013","DOI":"10.1371\/journal.pone.0119013","volume":"10","author":"G Li","year":"2015","unstructured":"Li G, Zhang J, Guo Q et al (2015) Efflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolates. PLoS ONE 10:e0119013. https:\/\/doi.org\/10.1371\/journal.pone.0119013","journal-title":"PLoS ONE"},{"key":"7095_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.tube.2015.01.005","volume":"95","author":"K Garima","year":"2015","unstructured":"Garima K, Pathak R, Tandon R et al (2015) Differential expression of efflux pump genes of Mycobacterium tuberculosis in response to varied subinhibitory concentrations of antituberculosis agents. Tuberculosis 95:155\u2013161. https:\/\/doi.org\/10.1016\/j.tube.2015.01.005","journal-title":"Tuberculosis"},{"key":"7095_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1089\/mdr.2008.0772","volume":"14","author":"X Jiang","year":"2008","unstructured":"Jiang X, Zhang W, Zhang Y et al (2008) Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by Real-Time Reverse Transcription PCR. Microb Drug Resist 14:7\u201311. https:\/\/doi.org\/10.1089\/mdr.2008.0772","journal-title":"Microb Drug Resist"},{"key":"7095_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3389\/fcimb.2020.00219","volume":"10","author":"J Tang","year":"2020","unstructured":"Tang J, Liu Z, Shi Y et al (2020) Whole genome and transcriptome sequencing of two multi-drug resistant Mycobacterium tuberculosis strains to facilitate illustrating their virulence in vivo. Front Cell Infect Microbiol 10:219. https:\/\/doi.org\/10.3389\/fcimb.2020.00219","journal-title":"Front Cell Infect Microbiol"},{"key":"7095_CR46","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/antibiotics3030317","volume":"3","author":"J Palomino","year":"2014","unstructured":"Palomino J, Martin A (2014) Drug resistance mechanisms in Mycobacterium tuberculosis. Antibiotics 3:317\u2013340. https:\/\/doi.org\/10.3390\/antibiotics3030317","journal-title":"Antibiotics"},{"key":"7095_CR47","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/jac\/dkr173","volume":"66","author":"PEAD Silva","year":"2011","unstructured":"Silva PEAD, Palomino JC (2011) Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. J Antimicrob Chemother 66:1417\u20131430. https:\/\/doi.org\/10.1093\/jac\/dkr173","journal-title":"J Antimicrob Chemother"},{"key":"7095_CR48","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/jac\/dkz564","volume":"75","author":"A Van Rie","year":"2020","unstructured":"Van Rie A, Whitfield MG, De Vos E et al (2020) Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact. J Antimicrob Chemother 75:1123\u20131129. https:\/\/doi.org\/10.1093\/jac\/dkz564","journal-title":"J Antimicrob Chemother"},{"key":"7095_CR49","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.3389\/fmicb.2018.02895","volume":"9","author":"Z Xu","year":"2018","unstructured":"Xu Z, Zhou A, Wu J et al (2018) Transcriptional approach for decoding the mechanism of rpoC compensatory mutations for the fitness cost in rifampicin-resistant Mycobacterium tuberculosis. Front Microbiol 9:2895. https:\/\/doi.org\/10.3389\/fmicb.2018.02895","journal-title":"Front Microbiol"},{"key":"7095_CR50","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1093\/jac\/dkz557","volume":"75","author":"D Atwine","year":"2020","unstructured":"Atwine D, Baudin E, Gel\u00e9 T et al (2020) Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug\u2013drug interaction randomized trial. J Antimicrob Chemother 75:1250\u20131258. https:\/\/doi.org\/10.1093\/jac\/dkz557","journal-title":"J Antimicrob Chemother"},{"key":"7095_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1099\/mic.0.000417","volume":"163","author":"S Rastogi","year":"2017","unstructured":"Rastogi S, Singh AK, Pant G et al (2017) Down-regulation of PE11, a cell wall associated esterase, enhances the biofilm growth of Mycobacterium tuberculosis and reduces cell wall virulence lipid levels. Microbiology 163:52\u201361. https:\/\/doi.org\/10.1099\/mic.0.000417","journal-title":"Microbiology"},{"key":"7095_CR52","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s12223-011-0080-7","volume":"56","author":"P Hao","year":"2011","unstructured":"Hao P, Shi-Liang Z, Ju L et al (2011) The role of ABC efflux pump, Rv1456c-Rv1457c-Rv1458c, from Mycobacterium tuberculosis clinical isolates in China. Folia Microbiol 56:549\u2013553. https:\/\/doi.org\/10.1007\/s12223-011-0080-7","journal-title":"Folia Microbiol"},{"key":"7095_CR53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1128\/jb.00932-08","volume":"191","author":"OH Vandal","year":"2008","unstructured":"Vandal OH, Roberts JA, Odaira T et al (2008) Acid-susceptible mutants of Mycobacterium tuberculosis share hypersusceptibility to cell wall and oxidative stress and to the host environment. J Bacteriol 191:625\u2013631. https:\/\/doi.org\/10.1128\/jb.00932-08","journal-title":"J Bacteriol"},{"key":"7095_CR54","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1128\/jb.84.5.1099-1103.1962","volume":"84","author":"M Forbes","year":"1962","unstructured":"Forbes M, Kuck NA, Peets EA (1962) MODE OF ACTION OF ETHAMBUTOL. J Bacteriol 84:1099\u20131103. https:\/\/doi.org\/10.1128\/jb.84.5.1099-1103.1962","journal-title":"J Bacteriol"},{"key":"7095_CR55","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/jac\/dkq120","volume":"65","author":"C Plinke","year":"2010","unstructured":"Plinke C, Cox HS, Zarkua N et al (2010) embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation. J Antimicrob Chemother 65:1359\u20131367. https:\/\/doi.org\/10.1093\/jac\/dkq120","journal-title":"J Antimicrob Chemother"},{"key":"7095_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0971-5916.154492","volume":"141","author":"S Singh","year":"2015","unstructured":"Singh S, Singh A, Gopinath K et al (2015) Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant. Indian J Med Res 141:27. https:\/\/doi.org\/10.4103\/0971-5916.154492","journal-title":"Indian J Med Res"},{"key":"7095_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijantimicag.2015.02.018","volume":"46","author":"L Zhou","year":"2015","unstructured":"Zhou L, Yang L, Zeng X et al (2015) Transcriptional and proteomic analyses of two-component response regulators in multidrug-resistant Mycobacterium tuberculosis. Int J Antimicrob Agents 46:73\u201381. https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.02.018","journal-title":"Int J Antimicrob Agents"},{"key":"7095_CR58","doi-asserted-by":"publisher","DOI":"10.1128\/9781555815783","volume-title":"The mycobacterial cell envelope","author":"M Daffe","year":"2008","unstructured":"Daffe M, Reyrat J-M (2008) The mycobacterial cell envelope. ASM Press, Washington, DC"},{"key":"7095_CR59","doi-asserted-by":"publisher","first-page":"8327","DOI":"10.1073\/pnas.0503272102","volume":"102","author":"J Rengarajan","year":"2005","unstructured":"Rengarajan J, Bloom BR, Rubin EJ (2005) From The Cover: Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc Natl Acad Sci USA 102:8327\u20138332. https:\/\/doi.org\/10.1073\/pnas.0503272102","journal-title":"Proc Natl Acad Sci USA"},{"key":"7095_CR60","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00100-11","author":"I Keren","year":"2011","unstructured":"Keren I, Minami S, Rubin E, Lewis K (2011) Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. mBio. https:\/\/doi.org\/10.1128\/mbio.00100-11","journal-title":"mBio"},{"key":"7095_CR61","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/mdr.2009.0054","volume":"16","author":"AK Gupta","year":"2010","unstructured":"Gupta AK, Katoch VM, Chauhan DS et al (2010) Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Microb Drug Resist 16:21\u201328. https:\/\/doi.org\/10.1089\/mdr.2009.0054","journal-title":"Microb Drug Resist"},{"key":"7095_CR62","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00438-015-1048-0","volume":"290","author":"SM Regmi","year":"2015","unstructured":"Regmi SM, Chaiprasert A, Kulawonganunchai S et al (2015) Whole genome sequence analysis of multidrug-resistant Mycobacterium tuberculosis Beijing isolates from an outbreak in Thailand. Mol Genet Genomics 290:1933\u20131941. https:\/\/doi.org\/10.1007\/s00438-015-1048-0","journal-title":"Mol Genet Genomics"},{"key":"7095_CR63","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1371\/journal.pcbi.0020137","volume":"2","author":"A Handel","year":"2006","unstructured":"Handel A, Regoes RR, Antia R (2006) The role of compensatory mutations in the emergence of drug resistance. PLoS Comput Biol 2:e137","journal-title":"PLoS Comput Biol"},{"key":"7095_CR64","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1477-5956-10-14","volume":"10","author":"N Singhal","year":"2012","unstructured":"Singhal N, Sharma P, Kumar M et al (2012) Analysis of intracellular expressed proteins of Mycobacterium tuberculosis clinical isolates. Proteome Sci 10:14. https:\/\/doi.org\/10.1186\/1477-5956-10-14","journal-title":"Proteome Sci"},{"key":"7095_CR65","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00203-016-1267-8","volume":"199","author":"S Yari","year":"2016","unstructured":"Yari S, Tasbiti AH, Ghanei M et al (2016) Proteomic analysis of drug-resistant Mycobacterium tuberculosis by one-dimensional gel electrophoresis and charge chromatography. Arch Microbiol 199:9\u201315. https:\/\/doi.org\/10.1007\/s00203-016-1267-8","journal-title":"Arch Microbiol"},{"key":"7095_CR66","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/jac\/dkq202","volume":"65","author":"KC Chang","year":"2010","unstructured":"Chang KC, Yew WW, Chan RCY (2010) Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 65:1551\u20131561. https:\/\/doi.org\/10.1093\/jac\/dkq202","journal-title":"J Antimicrob Chemother"},{"key":"7095_CR67","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1128\/.61.3.377-392.1997","volume":"61","author":"K Drlica","year":"1997","unstructured":"Drlica K, Zhao X (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 61:377\u2013392. https:\/\/doi.org\/10.1128\/.61.3.377-392.1997","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"7095_CR68","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.26226\/morressier.56d6be6fd462b80296c96e3d","volume":"60","author":"P-R Hsueh","year":"2016","unstructured":"Hsueh P-R (2016) Mutations in gyrA and gyrB among fluoroquinolone- and multidrug-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother. 60(4):2090\u20132096. https:\/\/doi.org\/10.26226\/morressier.56d6be6fd462b80296c96e3d","journal-title":"Antimicrob Agents Chemother."},{"key":"7095_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa109","author":"S Yoshida","year":"2020","unstructured":"Yoshida S, Iwamoto T, Arikawa K et al (2020) Bacterial population kinetics in heteroresistant Mycobacterium tuberculosis harbouring rare resistance-conferring mutations in gyrA and rpoB imply an epistatic interaction of mutations in a pre-XDR-TB patient. J Antimicrob Chemother. https:\/\/doi.org\/10.1093\/jac\/dkaa109","journal-title":"J Antimicrob Chemother"},{"key":"7095_CR70","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","volume":"17","author":"Y Pommier","year":"2010","unstructured":"Pommier Y, Leo E, Zhang H, Marchand C (2010) DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 17:421\u2013433. https:\/\/doi.org\/10.1016\/j.chembiol.2010.04.012","journal-title":"Chem Biol"},{"key":"7095_CR71","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/jac\/dkn387","volume":"62","author":"DM O'Sullivan","year":"2008","unstructured":"O\u2019Sullivan DM, Hinds J, Butcher PD et al (2008) Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin. J Antimicrob Chemother 62:1199\u20131202. https:\/\/doi.org\/10.1093\/jac\/dkn387","journal-title":"J Antimicrob Chemother"},{"key":"7095_CR72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","volume":"36","author":"DR Prevots","year":"2015","unstructured":"Prevots DR, Marras TK (2015) Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 36:13\u201334. https:\/\/doi.org\/10.1016\/j.ccm.2014.10.002","journal-title":"Clin Chest Med"},{"key":"7095_CR73","doi-asserted-by":"publisher","DOI":"10.1128\/genomea.00850-16","author":"HL Aung","year":"2016","unstructured":"Aung HL, Tun T, Permina E et al (2016) Draft genome sequences of two drug-resistant Mycobacterium tuberculosis isolates from Myanmar. Genome Announc. https:\/\/doi.org\/10.1128\/genomea.00850-16","journal-title":"Genome Announc"},{"key":"7095_CR74","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/jac\/dkr109","volume":"66","author":"A Engstrom","year":"2011","unstructured":"Engstrom A, Perskvist N, Werngren J et al (2011) Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 66:1247\u20131254. https:\/\/doi.org\/10.1093\/jac\/dkr109","journal-title":"J Antimicrob Chemother"},{"key":"7095_CR75","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.micpath.2017.09.055","volume":"112","author":"Z Habib","year":"2017","unstructured":"Habib Z, Xu W, Jamal M et al (2017) Adaptive gene profiling of Mycobacterium tuberculosis during sub-lethal kanamycin exposure. Microb Pathog 112:243\u2013253. https:\/\/doi.org\/10.1016\/j.micpath.2017.09.055","journal-title":"Microb Pathog"},{"key":"7095_CR76","doi-asserted-by":"publisher","first-page":"10483","DOI":"10.1074\/jbc.M112.420380","volume":"288","author":"L Goltermann","year":"2013","unstructured":"Goltermann L, Good L, Bentin T (2013) Chaperonins fight aminoglycoside-induced protein misfolding and promote short-term tolerance in Escherichia coli. J Biol Chem 288:10483\u201310489","journal-title":"J Biol Chem"},{"key":"7095_CR77","doi-asserted-by":"publisher","first-page":"e5150","DOI":"10.1371\/journal.pone.0005150","volume":"4","author":"Y Hu","year":"2009","unstructured":"Hu Y, Coates ARM (2009) Acute and persistent Mycobacterium tuberculosis infections depend on the thiol peroxidase TPX. PLoS ONE 4:e5150. https:\/\/doi.org\/10.1371\/journal.pone.0005150","journal-title":"PLoS ONE"},{"key":"7095_CR78","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fcimb.2017.00240","volume":"7","author":"D Sharma","year":"2017","unstructured":"Sharma D, Bisht D (2017) Role of Bacterioferritin & Ferritin in M. tuberculosis pathogenesis and drug resistance: a future perspective by interactomic approach. Front Cell Infect Microbiol 7:240. https:\/\/doi.org\/10.3389\/fcimb.2017.00240","journal-title":"Front Cell Infect Microbiol"},{"key":"7095_CR79","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jprot.2013.08.025","volume":"94","author":"B Kumar","year":"2013","unstructured":"Kumar B, Sharma D, Sharma P et al (2013) Proteomic analysis of Mycobacterium tuberculosis isolates resistant to kanamycin and amikacin. J Proteom 94:68\u201377. https:\/\/doi.org\/10.1016\/j.jprot.2013.08.025","journal-title":"J Proteom"},{"key":"7095_CR80","doi-asserted-by":"publisher","first-page":"e0139414","DOI":"10.1371\/journal.pone.0139414","volume":"10","author":"D Sharma","year":"2015","unstructured":"Sharma D, Kumar B, Lata M et al (2015) Comparative proteomic analysis of aminoglycosides resistant and susceptible Mycobacterium tuberculosis clinical isolates for exploring potential drug targets. PLoS ONE 10:e0139414. https:\/\/doi.org\/10.1371\/journal.pone.0139414","journal-title":"PLoS ONE"},{"key":"7095_CR81","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1365-2958.1993.tb01253.x","volume":"9","author":"M Finken","year":"1993","unstructured":"Finken M, Kirschner P, Meier A et al (1993) Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol 9:1239\u20131246. https:\/\/doi.org\/10.1111\/j.1365-2958.1993.tb01253.x","journal-title":"Mol Microbiol"},{"key":"7095_CR82","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1128\/aac.38.2.238","volume":"38","author":"N Honore","year":"1994","unstructured":"Honore N, Cole ST (1994) Streptomycin resistance in mycobacteria. Antimicrob Agents Chemother 38:238\u2013242. https:\/\/doi.org\/10.1128\/aac.38.2.238","journal-title":"Antimicrob Agents Chemother"},{"key":"7095_CR83","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1365-2958.1993.tb00924.x","volume":"10","author":"J Nair","year":"1993","unstructured":"Nair J, Rouse DA, Bai G-H, Morris SL (1993) The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis. Mol Microbiol 10:521\u2013527. https:\/\/doi.org\/10.1111\/j.1365-2958.1993.tb00924.x","journal-title":"Mol Microbiol"},{"key":"7095_CR84","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/j.1460-2075.1989.tb03494.x","volume":"8","author":"EAD Stasio","year":"1989","unstructured":"Stasio EAD, Moazed D, Noller HF, Dahlberg AE (1989) Mutations in 16S ribosomal RNA disrupt antibiotic-RNA interactions. EMBO J 8:1213\u20131216. https:\/\/doi.org\/10.1002\/j.1460-2075.1989.tb03494.x","journal-title":"EMBO J"},{"key":"7095_CR85","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1477-5956-8-59","volume":"8","author":"P Sharma","year":"2010","unstructured":"Sharma P, Kumar B, Gupta Y et al (2010) Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis. Proteome Sci 8:59. https:\/\/doi.org\/10.1186\/1477-5956-8-59","journal-title":"Proteome Sci"},{"key":"7095_CR86","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1099\/mic.0.024802-0","volume":"155","author":"R Provvedi","year":"2009","unstructured":"Provvedi R, Boldrin F, Falciani F et al (2009) Global transcriptional response to vancomycin in Mycobacterium tuberculosis. Microbiology 155:1093\u20131102. https:\/\/doi.org\/10.1099\/mic.0.024802-0","journal-title":"Microbiology"},{"key":"7095_CR87","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev.pharmtox.42.091601.142813","volume":"42","author":"J Pootoolal","year":"2002","unstructured":"Pootoolal J, Neu J, Wright GD (2002) GLYCOPEPTIDEANTIBIOTICRESISTANCE. Annu Rev Pharmacol Toxicol 42:381\u2013408. https:\/\/doi.org\/10.1146\/annurev.pharmtox.42.091601.142813","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"7095_CR88","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nm.1915","volume":"15","author":"WP Gill","year":"2009","unstructured":"Gill WP, Harik NS, Whiddon MR et al (2009) A replication clock for Mycobacterium tuberculosis. Nat Med 15:211\u2013214. https:\/\/doi.org\/10.1038\/nm.1915","journal-title":"Nat Med"},{"key":"7095_CR89","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/genetics\/154.3.985","volume":"154","author":"BR Levin","year":"2000","unstructured":"Levin BR, Perrot V, Walker N (2000) Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 154:985\u2013997","journal-title":"Genetics"},{"key":"7095_CR90","doi-asserted-by":"publisher","first-page":"e38200","DOI":"10.7554\/eLife.38200","volume":"7","author":"M Merker","year":"2018","unstructured":"Merker M, Barbier M, Cox H et al (2018) Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia. Elife 7:e38200","journal-title":"Elife"},{"key":"7095_CR91","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/ncomms2599","volume":"4","author":"S Ray","year":"2013","unstructured":"Ray S, Panova T, Miller G et al (2013) Topoisomerase II\u03b1 promotes activation of RNA polymerase I transcription by facilitating pre-initiation complex formation. Nat Commun 4:1598. https:\/\/doi.org\/10.1038\/ncomms2599","journal-title":"Nat Commun"},{"key":"7095_CR92","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.drudis.2017.01.002","volume":"22","author":"L Rodrigues","year":"2017","unstructured":"Rodrigues L, Parish T, Balganesh M, Ainsa JA (2017) Antituberculosis drugs: reducing efflux= increasing activity. Drug Discov Today 22:592\u2013599","journal-title":"Drug Discov Today"},{"key":"7095_CR93","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41429-019-0146-3","volume":"72","author":"AS Panja","year":"2019","unstructured":"Panja AS, Sarkar A, Biswas R et al (2019) Modification of drug-binding proteins associated with the efflux pump in MDR-MTB in course of evolution: an unraveled clue based on in silico approach. J Antibiot 72:282\u2013290","journal-title":"J Antibiot"},{"key":"7095_CR94","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1574-6976.2005.00002.x","volume":"30","author":"ED Rossi","year":"2006","unstructured":"Rossi ED, A\u00ednsa JA, Riccardi G (2006) Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol Rev 30:36\u201352. https:\/\/doi.org\/10.1111\/j.1574-6976.2005.00002.x","journal-title":"FEMS Microbiol Rev"},{"key":"7095_CR95","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1128\/aac.39.8.1700","volume":"39","author":"GJ Alangaden","year":"1995","unstructured":"Alangaden GJ, Manavathu EK, Vakulenko SB et al (1995) Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients. Antimicrob Agents Chemother 39:1700\u20131703. https:\/\/doi.org\/10.1128\/aac.39.8.1700","journal-title":"Antimicrob Agents Chemother"},{"key":"7095_CR96","doi-asserted-by":"publisher","first-page":"e13938","DOI":"10.1371\/journal.pone.0013938","volume":"5","author":"NA Kruh","year":"2010","unstructured":"Kruh NA, Troudt J, Izzo A et al (2010) Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo. PLoS ONE 5:e13938. https:\/\/doi.org\/10.1371\/journal.pone.0013938","journal-title":"PLoS ONE"},{"key":"7095_CR97","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1038\/s41598-021-82905-x","volume":"11","author":"P Aiewsakun","year":"2021","unstructured":"Aiewsakun P, Prombutara P, Siregar TAP et al (2021) Transcriptional response to the host cell environment of a multidrug-resistant Mycobacterium tuberculosis clonal outbreak Beijing strain reveals its pathogenic features. Sci Rep 11:3199. https:\/\/doi.org\/10.1038\/s41598-021-82905-x","journal-title":"Sci Rep"},{"key":"7095_CR98","doi-asserted-by":"publisher","first-page":"13227","DOI":"10.1073\/pnas.95.22.13227","volume":"95","author":"D Alland","year":"1998","unstructured":"Alland D, Kramnik I, Weisbrod TR et al (1998) Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): The effect of isoniazid on gene expression in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 95:13227\u201313232. https:\/\/doi.org\/10.1073\/pnas.95.22.13227","journal-title":"Proc Natl Acad Sci USA"},{"key":"7095_CR99","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1074\/jbc.RA119.011373","volume":"295","author":"S Samanta","year":"2020","unstructured":"Samanta S, Biswas P, Banerjee A et al (2020) A universal stress protein in Mycobacterium smegmatis sequesters the cAMP-regulated lysine acyltransferase and is essential for biofilm formation. J Biol Chem 295:1500\u20131516","journal-title":"J Biol Chem"},{"key":"7095_CR100","doi-asserted-by":"publisher","unstructured":"Sriraman K, Kekane R, Shah D, et al (2019) Expression of ppsD, a gene involved in synthesis of Mycobacterium tuberculosis virulence factor PDIM, reflects treatment response in pulmonary tuberculosis patients. https:\/\/doi.org\/10.1101\/576470","DOI":"10.1101\/576470"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-07095-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-07095-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-07095-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T20:22:17Z","timestamp":1654633337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-07095-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,23]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["7095"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-07095-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,23]]},"assertion":[{"value":"10 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants or animals"}}]}}